Symptomatic intracranial stenoses are an important cause of stroke and have a high risk of recurrent stroke with medical therapy. The Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Arterial Stenosis (SAMMPRIS) trial unexpectedly showed a higher-than-expected rate of complications with intracranial stenting and a lower-than-expected recurrence rate wit...

Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. pISSN 1226-3303 eISSN 2005-664...

a bstract background: non‑medical utilization of pre‑implantation genetic diagnosis (pgd), like sex selection, is increasing, therefore it is necessary to follow‑up the health and outcome of fertilization and newborn’s birth followed pgd. the aim of this study was to evaluate the outcome of fertilization after sex selection by pgd and the relation between the age of parents and the outcome of f...

Under 5 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 560 6.0 5 to 9 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 535 5.7 10 to 14 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 556 5.9 15 to 19 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 616 6.5 20 to 24 years . . . . . . . . . . . . . . . . . . . . ....

616 Nefrologia 2011;31(5):607-26 at a dosage of 180mg/12 hours. This treatment is maintained to date. Vesical transurethral resection in 2009 due to vesical neoplasm and atrial fibrillation. His usual treatment was: acetylsalicylic acid 100mg, bisoprolol 2.5mg/24 hours, omeprazole 20mg/24 hours, calcium carbonate 2.5g/24 hours, dacortin 5mg/24 hours and MMF 180mg/24 hours. He was administered E...

Corresponding author: Magdalena Magnowska MD, PhD Department of Gynecology, Obstetrics and Gynecologic Oncology Division of Gynecologic Oncology Poznan University of Medical Sciences 33 Polna St 60-535 Poznan, Poland Phone: +48 618 419 330 Fax: +48 616 599 645 E-mail: [email protected] 1 Department of Gynecology, Obstetrics and Gynecologic Oncology, Division of Gynecologic Oncology, Poznan Universit...

PERSPECTIVES AND SUMMARY .............................................................. 615 HISTORY ............................................................................................... 616 INDIVIDUAL G PROTEINS: FUNCTIONS AND MOLECULAR ENTITIES .......... 617 Criteria .for Involvement of a G Protein ..................................................... 618 Functions Regulated by G Pr...

Introduction ........................................................................................610 I. Business and Technological Realities in the World of Biotechnology ...........................................................................611 II. Reach-Through Patent Claims .................................................616 III. Fundamental Legal Framework for Treatment of ReachThr...

This entity usually affects young patients; in Japan the disease tends to affect children (range: 616 years old) with higher frequency, while in the other countries where this disorder has been described, the affected population is older, ranging from 23 to 29 years old .Slighthly more males have been reported than females (52% versus 48%). This condition is typically bilateral, but unilateral ...

The Medical Journal of Australia ISSN: 0025729X 15 November 2010 193 10 616-617 ©The Medical Journal of Australia 2010 www.mja.com.au Lessons from Practice which he was previously treated with immunosuppressio his asymptomatic, stable, moderate thrombocytopenia count, 50–60 10/L), there had never been evidence o or thrombosis. The patient took no regular prescription and had previously document...